Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in ... late-stage ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Published Just now A new weight loss drug target may help reduce appetite and burn calories without causing sickness, ...

Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Cantor analysts said they found the bone mineral density changes when reviewing supplemental data that was published along ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...